Isoginkgetin derivative IP2 enhances the adaptive immune response against tumor antigens
Darrigrand, Pierson et al. study the effect of mRNA splicing inhibitors on the generation of the MHC class I ligands. They developed a derivative of the spliceosome inhibitor isoginkgetin which is less toxic and more effective at enhancing antigen presentation and CD8+ T cell activation and showed g...
Guardado en:
Autores principales: | Romain Darrigrand, Alison Pierson, Marine Rouillon, Dolor Renko, Mathilde Boulpicante, David Bouyssié, Emmanuelle Mouton-Barbosa, Julien Marcoux, Camille Garcia, Michael Ghosh, Mouad Alami, Sébastien Apcher |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1c8392da73b6409daf3965425089b16d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Isoginkgetin attenuates endoplasmic reticulum stress-induced autophagy of brain after ischemic reperfusion injury
por: Yueyong Li, et al.
Publicado: (2021) -
Natural Phytochemicals, Luteolin and Isoginkgetin, Inhibit 3C Protease and Infection of FMDV, In Silico and In Vitro
por: Sirin Theerawatanasirikul, et al.
Publicado: (2021) -
The IP litigator devoted to intellectual property litigation and enforcement.
Publicado: (1995) -
COMPARATIVE ANALYSIS OF CRISPR-CAS SYSTEM STRUCTURES OF YERSINIA PSEUDOTUBERCULOSIS IP32953 AND IP31758
por: N. P. Peretolchina, et al.
Publicado: (2018) -
Identification of significant chromatin contacts from HiChIP data by FitHiChIP
por: Sourya Bhattacharyya, et al.
Publicado: (2019)